NeuroTalk Support Groups

NeuroTalk Support Groups (https://www.neurotalk.org/)
-   Parkinson's Disease (https://www.neurotalk.org/parkinson-s-disease/)
-   -   Rytary approved (https://www.neurotalk.org/parkinson-s-disease/214490-rytary-approved.html)

GerryW 01-08-2015 10:13 AM

Rytary approved
 
http://www.pharmacytimes.com/product...ews+1%2D8%2D15

Tupelo3 01-08-2015 12:38 PM

Quote:

Originally Posted by GerryW (Post 1117016)

Given the history of their manufacturing problems, people may want to wait a few months before trying it to make sure there are no reported issues.

ashleyk 01-08-2015 03:38 PM

Good news, bad news
 
After reading the company precautions on rytary, I wonder how many will qualify to take this drug. Not my wife who has had PD for 13 years and has very serious hallucinations.

http://www.prnewswire.com/news-relea...300017730.html

soccertese 01-09-2015 10:53 AM

Quote:

Originally Posted by ashleyk (Post 1117062)
After reading the company precautions on rytary, I wonder how many will qualify to take this drug. Not my wife who has had PD for 13 years and has very serious hallucinations.

http://www.prnewswire.com/news-relea...300017730.html

read the insert for carbidopa/levodopa, likely very similar warnings.

if water came with a FDA required insert we likely wouldn't drink it.

will be very expensive.

soccertese 01-10-2015 11:28 AM

parkinson's disease foundation video on rytary release
 
imho not much of an endorsement, they think it will cost $9/day or similar to stalevo
https://www.youtube.com/watch?v=uPjnpKth40o

Tupelo3 01-10-2015 12:43 PM

Quote:

Originally Posted by soccertese (Post 1117379)
imho not much of an endorsement, they think it will cost $9/day or similar to stalevo
https://www.youtube.com/watch?v=uPjnpKth40o

I was on an analyst call with the company. They still haven't release pricing information but some are predicting as high as $12/day. It will be interesting to see what the health insurers do in terms of coverage. Wouldn't be surprised to see some refuse to cover the drug.

soccertese 01-10-2015 03:47 PM

i know advanced pd'ers on generic requip, stalevo and amantadine. if you can take rytary and eliminate the amantadine and/or requip, then insco's would go for it.
$9 is similar to stalevo's price and you eliminate COMTAN side affects and insco's pay for stalevo.

whether a patient wants to wean off of an agonist is a big decision imho.

wonder if impax will conduct some trial on that switchover?

damon4309 01-12-2015 02:05 PM

Rytary
 
How does this new med differ from carbo/levo 50/200 extended release?
Thank you
Damon

soccertese 01-12-2015 02:42 PM

Quote:

Originally Posted by damon4309 (Post 1117881)
How does this new med differ from carbo/levo 50/200 extended release?
Thank you
Damon

supposed to be superior but they didn't test it against 50/200CR or stalevo.

damon4309 01-12-2015 05:28 PM

Rotary
 
Quote:

Originally Posted by soccertese (Post 1117902)
supposed to be superior but they didn't test it against 50/200CR or stalevo.

FRom what I can tell the 50/200 doesn't work all that well. My MDS states she has seen that in many patients
Damon


All times are GMT -5. The time now is 02:53 PM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.